|
End-of-day quote
Korea S.E.
06/11/2026
|
5-day change | 1st Jan Change | ||
| 211,000.00 KRW | -1.86% |
|
+11.46% | +22.40% |
| 11-03 | Celltrion Gets European Approval for Rheumatoid Arthritis Drug Trial | MT |
| 10-30 | South Korea's FTC Fines Celltrion KRW630 Million Over Subcontracting Violations During Covid-19 Pandemic | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.86% | +11.46% | +15.55% | +10.88% | +22.40% | +26.67% | +61.40% | +22.80% | +180.36% | 36.31B | |
| -4.83% | +2.88% | -12.15% | -0.34% | +62.18% | +55.87% | +69.12% | +16.30% | - | 69.4B | |
| +0.02% | +1.07% | -2.28% | +8.22% | +13.81% | +10.63% | +76.66% | +198.17% | +6,189.90% | 57.24B | |
| -1.34% | +2.98% | +15.13% | +17.08% | +23.35% | +24.79% | +100.18% | -7.19% | +267.33% | 57.62B | |
| +2.67% | +1.50% | +4.37% | +16.74% | +20.38% | +28.68% | +36.77% | +7.89% | +263.78% | 43.65B | |
| +5.35% | +10.14% | +12.43% | +23.67% | +34.25% | +22.72% | +107.95% | +16.59% | +1,176.99% | 44.03B | |
| +6.97% | -0.16% | -4.43% | -3.44% | +139.81% | +211.19% | +786.77% | +483.59% | - | 38.08B | |
| -2.97% | -9.84% | +42.10% | +87.91% | +74.00% | +88.86% | +76.17% | +17.18% | +196.64% | 32.61B | |
| -2.18% | +5.68% | -14.04% | +17.23% | +51.46% | +36.21% | -0.69% | -53.27% | - | 25.47B | |
| +2.37% | -1.41% | +5.47% | -16.27% | -36.23% | -40.23% | +365.56% | +238.07% | +842.99% | 23.86B | |
| +1.19% | -1.08% | -8.89% | -4.35% | -8.38% | -15.61% | -12.53% | -64.05% | - | 21.29B | |
| +2.69% | -0.12% | +8.02% | +11.32% | +15.95% | +9.97% | +141.76% | +190.00% | +1,953.07% | 17.76B | |
| +0.49% | -0.50% | +18.37% | +32.27% | +57.53% | +69.23% | +231.31% | +268.04% | +458.62% | 16.77B | |
| -0.45% | +1.05% | +16.42% | +26.85% | +42.05% | +51.21% | +74.63% | -13.29% | +120.47% | 17.35B | |
| +0.72% | +1.87% | +13.24% | +2.45% | - | - | - | - | - | 16.64B | |
| +7.17% | +2.42% | +6.72% | -4.87% | +199.74% | +184.32% | +358.47% | +1,547.39% | +865.04% | 14.86B | |
| +7.13% | -7.02% | +9.58% | +25.87% | +67.53% | +95.57% | +84.26% | -10.61% | +375.44% | 15B | |
| +1.54% | -3.12% | +26.64% | +27.05% | +12.37% | +27.98% | -20.60% | -23.61% | +167.14% | 15.11B | |
| +5.64% | +1.77% | +2.10% | +59.36% | +24.46% | +1.95% | - | - | - | 12.85B | |
| -1.52% | +3.88% | -3.19% | -7.52% | +15.96% | +4.74% | +459.41% | - | - | 14.07B | |
| Average | +1.48% | -0.33% | +7.56% | +16.51% | +43.82% | +47.09% | +166.48% | +166.71% | +1,004.44% | 29.5B | |
| Weighted average by Cap. | +0.73% | +0.93% | +6.06% | +15.13% | +42.47% | +46.43% | +151.41% | +120.81% | +1,355.56% |
- Stock Market
- Stocks
- A068270 Stock
- Sector Celltrion, Inc.
Select your edition
All financial news and data tailored to specific country editions
